Stavudine, lamivudine, nevirapine drug combination
Showing 9976 - 10000 of >10,000
Pectus Excavatum Trial in Brisbane (PCL Pectus Scaffold implantation and autologous fat grafting)
Recruiting
- Pectus Excavatum
- PCL Pectus Scaffold implantation and autologous fat grafting
-
Brisbane, Queensland, AustraliaPrincess Alexandra Hospital - Wooloongabba
Nov 17, 2022
Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 2, 2023
Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)
Terminated
- Neuroblastoma Recurrent
- Naxitamab and GM-CSF in combination with irinotecan and temozolomide
-
Hong Kong, Hong Kong
- +2 more
Nov 8, 2022
Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)
Terminated
- Solid Tumor
- Unresectable or Metastatic Melanoma
-
Duarte, California
- +26 more
Nov 2, 2021
Implementation ofNovel Functional Eye-Tracking Biomarker for
Recruiting
- Clinically Isolated Syndrome
- Relapsing Remitting Multiple Sclerosis
- Eye-tracking
-
Montréal, Quebec, CanadaMontreal Neurological Institute and Hospital
Sep 2, 2022
Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)
Recruiting
- Cholangiocarcinoma
- Combination of Lonsurf® and Irinotecan
-
Düsseldorf, NRW, GermanyKlinik für Gastroenterologie, Hepatologie und Infektiologie
Dec 22, 2022
Cardiovascular Disorder, Diabetes Trial (ezetimibe (+) simvastatin, simvastatin 40 mg or atorvastatin 20 mg, Rosuvastatin)
Completed
- Cardiovascular Disorder
- Diabetes Mellitus
- ezetimibe (+) simvastatin
- +3 more
- (no location specified)
Feb 7, 2022
Drug Toxicity Trial in Rawalpindi (N-Acetylcysteine, Chemotherapy)
Active, not recruiting
- Drug Toxicity
-
Rawalpindi, Punjab, PakistanMedical Oncology department, Fauji Foundation Hospital
Aug 25, 2023
Inguinal Hernia, Urinary Retention Trial in Larissa (Tamsulosin, Placebo oral tablet)
Completed
- Inguinal Hernia
- Urinary Retention
- Tamsulosin
- Placebo oral tablet
-
Larissa, Greece
- +1 more
Nov 23, 2021
Pregnancy Related Trial in Ukraine (Human Anti-D (rh) immunoglobulin)
Recruiting
- Pregnancy Related
- Human Anti-D (rh) immunoglobulin
-
Cherkasy, Cherkasy Region, Ukraine
- +15 more
Jun 23, 2022
Metastatic Renal Cell Cancer Trial in United States (Axitinib)
Active, not recruiting
- Metastatic Renal Cell Cancer
-
Duarte, California
- +3 more
Jun 1, 2022
Melanoma Trial in Boston (Trametinib, Dabrafenib, INCB039110)
Active, not recruiting
- Melanoma
- Trametinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 1, 2021
Glioma, Glioblastoma Trial in Winston-Salem (Soliramfetol)
Recruiting
- Glioma
- Glioblastoma
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 31, 2022
Application of N-of-1 Rheumatoid Arthritis
Not yet recruiting
- Arthritis, Rheumatoid
- Adalimumab
- +2 more
-
Boston, MassachusettsTufts Medical Center
Aug 24, 2023
Symptomatic Improvement in Fibromyalgia by Means ofFood
Completed
- Fibromyalgia
- Food supplement
-
Barcelona, SpainHospital Clínic Barcelona
Feb 8, 2023
Patients Referred toSubstance Abuse Liaison Department
Recruiting
- Substance Abuse
- +3 more
-
Amiens, FranceCHU Amiens
Jun 7, 2021
Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)
Recruiting
- Lung Cancer
- AMG 510
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
B-Cell Acute Lymphoblastic Leukemia, Adult Trial in La Jolla, Orange, San Francisco (blinatumomab, pembrolizumab)
Terminated
- B-Cell Acute Lymphoblastic Leukemia, Adult
-
La Jolla, California
- +2 more
Apr 26, 2022
Kidney Transplant, Type 2 Diabetes Trial in United States (Empagliflozin)
Not yet recruiting
- Kidney Transplant
- Type 2 Diabetes
-
Iowa City, Iowa
- +3 more
Aug 22, 2023
Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder Trial
Not yet recruiting
- Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
- Polymorphic Post-Transplant Lymphoproliferative Disorder
- Biopsy
- +5 more
-
New Brunswick, New Jersey
- +2 more
Mar 23, 2023